Kidder Stephen W Trims Stock Holdings in Danaher Corporation $DHR

Kidder Stephen W reduced its stake in Danaher Corporation (NYSE:DHR) by 0.3% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 36,471 shares of the conglomerate’s stock after selling 112 shares during the period. Danaher makes up approximately 2.2% of Kidder Stephen W’s portfolio, making the stock its 20th biggest position. Kidder Stephen W’s holdings in Danaher were worth $7,204,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Somerville Kurt F raised its holdings in Danaher by 1.2% in the 2nd quarter. Somerville Kurt F now owns 79,376 shares of the conglomerate’s stock valued at $15,680,000 after buying an additional 962 shares during the period. REAP Financial Group LLC raised its holdings in Danaher by 197.3% in the 2nd quarter. REAP Financial Group LLC now owns 440 shares of the conglomerate’s stock valued at $87,000 after buying an additional 292 shares during the period. Venturi Wealth Management LLC raised its holdings in Danaher by 1,901.9% in the 2nd quarter. Venturi Wealth Management LLC now owns 66,764 shares of the conglomerate’s stock valued at $13,189,000 after buying an additional 63,429 shares during the period. BankPlus Trust Department raised its holdings in Danaher by 6.1% in the 2nd quarter. BankPlus Trust Department now owns 3,575 shares of the conglomerate’s stock valued at $706,000 after buying an additional 207 shares during the period. Finally, SGL Investment Advisors Inc. purchased a new stake in Danaher in the 2nd quarter valued at about $341,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total value of $586,324.68. Following the completion of the transaction, the director owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 11.20% of the company’s stock.

Danaher Stock Down 1.5%

DHR stock opened at $208.63 on Wednesday. The company’s 50 day moving average price is $200.40 and its 200 day moving average price is $197.32. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a fifty-two week low of $171.00 and a fifty-two week high of $279.41. The firm has a market capitalization of $149.39 billion, a price-to-earnings ratio of 44.39, a PEG ratio of 3.02 and a beta of 0.77.

Danaher (NYSE:DHR) last released its earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 earnings per share for the quarter, topping analysts’ consensus estimates of $1.64 by $0.16. Danaher had a net margin of 14.21% and a return on equity of 10.70%. The firm had revenue of $5.94 billion for the quarter, compared to analyst estimates of $5.83 billion. During the same period in the prior year, the firm earned $1.72 earnings per share. The business’s quarterly revenue was up 3.4% compared to the same quarter last year. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, equities research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $1.28 dividend on an annualized basis and a yield of 0.6%. Danaher’s dividend payout ratio (DPR) is presently 27.23%.

Wall Street Analysts Forecast Growth

A number of analysts have issued reports on DHR shares. Evercore ISI boosted their price target on shares of Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research note on Tuesday. Weiss Ratings reiterated a “hold (c-)” rating on shares of Danaher in a research note on Saturday, September 27th. Scotiabank upgraded shares of Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price target on the stock in a research note on Friday, July 11th. Guggenheim reiterated a “buy” rating and set a $250.00 price target on shares of Danaher in a research note on Wednesday, July 23rd. Finally, Royal Bank Of Canada set a $241.00 price target on shares of Danaher in a research note on Tuesday, September 2nd. Seventeen equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average target price of $245.63.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.